Stewart-Treves-Syndrome in chronic arm lymphedema following mastectomy. Case report;Stewart-Treves-Syndrom bei chronischem armlymphödem nach radikaler mastektomie. Ein fallbericht

Lymphologie in Forschung und Praxis

Volumn 7, Issue 2, 2003, Pages 81-83

  Döller, Walter ^a,b   Apich, G ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

^b Rehabilitationsklinik für Lymphangiologische Rehabilitation Mit Akut Station   (Austria)

Author keywords

Curative and palliative therapy; Early tumor detection; Preventative measures; Stewart Treves Syndrome

Indexed keywords

AGED; ARM; ARTICLE; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CASE REPORT; EARLY DIAGNOSIS; FEMALE; HUMAN; LYMPHEDEMA; MALIGNANT NEOPLASTIC DISEASE; MASTECTOMY; STANDARD; STEWART TREVES SYNDROME; SURVIVAL RATE;

EID: 0347355176     PISSN: 14335255     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bach AD, Walgenbach KJ, Horch RE: Hämangiosarkom der linken Hand bei einem Patienten mit der seltenen Kombination eines Maffucci's mit einem Stewart Treves Syndrom VASA 2000;29(1)
2. Baes H: Angiosarcoma in a chronic lymphedematous leg. Dermatlogica 1967;134:331-336
3. Cozen W, Bemstein L, Wang F, Press MF, Mack TM: The risk of angiosarcoma following primary breast cancer. Br J Cancer 1999,81:532-536
4. Creech O Jr, Krementz E, Ryan J, Winblad J: Chemotherapy of cancer: regional perfusion utilising an extracorporal circuit. Ann Surg 1958; 148:616-632
5. Deutschmann W, Smola MG, Schamagl E, Beham A: Stewart-Treves-Syndrom und Lymphangiosarcom. Chirurg 1988; 59: 605
6. Dubin HV, Creehan EP, Headington JT: Lymphangiosarcoma arising in congenitial lymphedema of the extremity. Arch Dermatol 1974; 10: 608-614
7. Grobmyer SR, Daly JM, Glotzbach RE, Gomyer AJ: Role of surgery in the management of post-mastectomy extremity angiosarcoma (Stewart-Treves-Syndrom) J Surg Oncol 2000; 73: 182-188
8. Lans TE, de Wilt JHW, van Geel AN, Eggermont AMM: Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Nonresectable Stewart-Treves Lymphanhiosarcoma. Ann Surg Oncol 2002; 9 (10)
9. Laskas JJ, Shelly WB, Wood MG: Lymphanagiosarcoma arising in congenital lymphedema. Arch Dermatil 1975; 111: 86-89
10. Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ: High-dose recombinant tumor-necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992;10:52-60
11. Manusama ER, Stavast J; Durante NM, Marquet RL, Eggermont AM: Isolated limb perfusion with TNF alpha and Melphalan in a rat osteosarcoma model: a new antitumor approach. Eur J Surg Oncol 1996;22:152-157
12. Muller R, Hajdu SI, Brennan MF. Lymphansarcoma associated with the chronic filarial lymphedema. Cancer. 1987;59:179-183
13. Sordillo PP, Chapman R, Hadju SI, Magill GB, Golbey RB: Lymphangiosarcoma. cancer 1981;48:1674-1679
14. Sordillo EM, Sordillo PP, Hadju SI, Good RA: Lyphangiosarcoma after filarial infection. J Dermatol Surg Oncol 1981;7:235-239
15. Stewart F, Treves N: Lyphangiosarcoma in postmastectomy lymphedema. Cancer 1948 1: 64-81
16. Woodward AH, Ivins JC, Soule EH: Lymphangiosarcoma arising in chronic lymphedematous extremities. Cancer 30:562(1972)